Study on Betterbrand's BetterLungs® Mullein + Chlorophyll Drops
Claim 1
By Day 60: 76% of participants agreed that they found it easier to clear chest mucus.
Claim 2
By Day 60: 76% of participants agreed that they have a reduced amount of mucus.
Claim 3
By Day 60: 79% of participants agreed that their airways were more clear.
About
Betterbrand
Betterbrand was founded by Dr. Chris, a former Army Combat Medic and Doctor of Pharmacy, with a mission to bridge the gap between natural wellness and science. After witnessing the limitations of traditional medicine and searching for better solutions for his own family, Dr. Chris launched Betterbrand to deliver effective, plant-based products backed by clinical research. The company’s core philosophy combines modern science with the healing wisdom of nature to provide natural remedies that work, without relying on pharmaceutical shortcuts.
What is BetterLungs® Mullein + Chlorophyll Drops?
BetterLungs® Mullein + Chlorophyll Drops is a daily lung support supplement designed for individuals who struggle with mucus buildup, breathlessness, or reduced respiratory energy, especially smokers or those exposed to environmental irritants. Powered by a potent blend of Mullein and Chlorophyll, this formula helps clear lung buildup, ease coughing, and support clearer breathing. With consistent use, users have reported easier respiration, less frequent coughing, and improved energy throughout the day.*
Study Design for
Betterbrand
BetterLungs® was evaluated in a randomized, triple-blind, placebo-controlled clinical trial conducted by Citruslabs over a 60-day period.
Participants: 100 adults (18+) with self-reported issues related to mucus buildup, fatigue, or breathlessness
Study Design: Participants were randomly assigned to receive either BetterLungs or a placebo. Neither the participants, researchers, nor data analysts knew which product was being administered.
Assessments: Data were collected at Baseline, Day 20, Day 40, and Day 60 via study-specific respiratory symptom questionnaires and the validated Fatigue Severity Scale (FSS).
Analysis: Statistical methods included Welch’s t-tests and Mann-Whitney tests with multiple comparison corrections. Perception-based responses were analyzed through combined agreement scores using Likert-scale questions.
Study Results for
Betterbrand
Validated Fatigue Reduction (FSS Score):
By Day 20, there was a significant reduction in fatigue, as measured by the Fatigue Severity Score, compared to the placebo group.
By Day 60, there was a significant reduction in fatigue, as measured by the Fatigue Severity Score, compared to the placebo group.
Participant-Reported Outcomes (Perception Data):
At Day 60, participants using BetterLungs® reported:
76.74% of participants agreed that they had experienced less breathlessness during daily activities.
72.09% of participants agreed that they had experienced less breathlessness during physical activities.
76.74% of participants agreed that they found it easier to clear chest mucus.
76.74% of participants agreed that they have a reduced amount of mucus.
79.07% of participants agreed that their airways were more clear.
Benefits of Clinical Research
In a market saturated with unverified wellness products, clinical validation remains the gold standard for transparency and trust. Betterbrand’s investment in a placebo-controlled, triple-blind study reinforces their commitment to proving that nature-based remedies can hold their own under scientific scrutiny. These trials not only confirm product efficacy but also help consumers make informed decisions grounded in evidence, not hype.
